Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- RUA.LSE
- Price
- 11.25
- Stock movement up
- +- (%)
- Company name
- Rua Life Sciences PLC
- Exchange
- (LSE ,
- Currency
- GBX )
- Sector
- Healthcare >Medical Devices
- Market cap
- 698.18M
- Ent value
- 695.23M
- Price/Sales
- 183.56
- Price/Book
- 97.21
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -1.77%
- 1 year return
- -2.17%
- 3 year return
- -39.38%
- 5 year return
- -33.34%
- 10 year return
- -7.49%
Last updated: 2025-04-12
DIVIDENDS
RUA.LSE does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 183.56 |
| Price to Book | 97.21 |
| EV to Sales | 182.79 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 62.06M |
| EPS (TTM) | -0.08 |
| FCF per share (TTM) | -0.09 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 3.80M |
| Gross profit (TTM) | 2.69M |
| Operating income (TTM) | -3.71M |
| Net income (TTM) | -2.73M |
| EPS (TTM) | -0.08 |
| EPS (1y forward) | -1.70 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 70.71% |
| Operating margin (TTM) | -97.54% |
| Profit margin (TTM) | -71.78% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 3.93M |
| Net receivables | 301.00K |
| Total current assets | 4.99M |
| Goodwill | 301.00K |
| Intangible assets | 419.00K |
| Property, plant and equipment | 3.53M |
| Total assets | 8.17M |
| Accounts payable | 140.00K |
| Short/Current long term debt | 389.00K |
| Total current liabilities | 554.00K |
| Total liabilities | 987.00K |
| Shareholder's equity | 7.18M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -2.40M |
| Capital expenditures (TTM) | 587.50K |
| Free cash flow (TTM) | -2.98M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -38.01% |
| Return on Assets | -33.42% |
| Return on Invested Capital | -36.74% |
| Cash Return on Invested Capital | -40.14% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 11.25 |
| Daily high | 11.25 |
| Daily low | 10.78 |
| Daily Volume | 95K |
| All-time high | 10700.00 |
| 1y analyst estimate | 25.00 |
| Beta | 1.12 |
| EPS (TTM) | -0.08 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 15 Jun 2025 |
Downside potential
Loading...
Downside potential data
| RUA.LSE | S&P500 | |
| Current price drop from All-time high | -99.89% | -12.89% |
| Highest price drop | -99.92% | -56.47% |
| Date of highest drop | 3 Apr 2024 | 9 Mar 2009 |
| Avg drop from high | -94.34% | -11.07% |
| Avg time to new high | 341 days | 12 days |
| Max time to new high | 5750 days | 1805 days |
COMPANY DETAILS
Marketcap
698.18M
Marketcap category
Small-cap
Description
RUA Life Sciences plc, together with its subsidiaries, engages in the provision of polymers, services, and products to the medical device industry in Europe, the United States, and internationally. The company operates through Biomaterials, Contract Manufacture, Vascular, and Structural Heart segments. The Biomaterials segment operates as depository of the Intellectual Property and licensing rights to a range of biostable and implantable polymers, including Elast-Eon and ECSil. The Contract Manufacture segment provides sub-contract manufacturing, assembly, packing and services to the medical device. The Vascular segment develops and commercializes bore polymer sealed grafts and soft tissue patches. The Structural Heart segment develops tri leaflet polymeric heart valves. The company was formerly known as AorTech International plc and changed its name to RUA Life Sciences plc in June 2020. RUA Life Sciences plc was incorporated in 1996 and is headquartered in Irvine, the United Kingdom.
Employees
40
Website
Investor relations
-
SEC filings
CEO
Country
UK
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found